Daily non-political popular news in brief.

Toxic releases down from North American industry leaders, increasing from other facilities

The latest Taking Stock report from the Commission for Environmental Cooperation reveals a continued decline in releases of toxic chemicals to the environment -- 15 percent for the US and Canada from 1998 to 2004 -- driven by a group of industrial facilities that are the largest generators of emissions.The report also, however, reveals a substantial increase in chemical releases and transfers by a much larger group of industrial facilities that report lower emission volumes.

Read more »

Keywords: toxic, releases, down, north, american, industry, leaders, increasing, facilities, release, leader, facility

« Previous | Next »

Similar news on "Toxic releases down from North American industry leaders, increasing from other facilities":

1. Statewide program helps improve quality of care for heart attack
   11-04-2007 · EurekAlert!
   Implementation of a program in North Carolina to increase the rate of coronary reperfusion for heart attack significantly improved the quality of care these patients received, according to a study in JAMA being released early online to coincide with its release at the American Heart Association's annual meeting. The study will be published in the Nov. 28 print issue of JAMA.
   Similar news · Read more »
   
2. Chi-Chang Kao Named Chair of the National Synchrotron Light Source at Brookhaven Lab
   10-10-2006 · Brookhaven National Laboratory
   Chi-Chang Kao, a physicist and leader in synchrotron light research, has been named Chair of the National Synchrotron Light Source (NSLS) Department, effective October 1. Kao had served as interim NSLS Chair since mid-January, after Steve Dierker stepped down to lead the development of the National Synchrotron Light Source II (NSLS-II), a proposed scientific user facility that would produce x-rays more than 10,000 times brighter than the current NSLS.
   Similar news · Read more »
   
3. Scientific American names Belcher top researcher
   11-06-2006 · Massachusetts Institute of Technology (MIT)
   Professor Angela Belcher has been named Research Leader of the Year by Scientific American. Three other MIT researchers are also among the magazine's annual list of the nation's top 50 technology leaders.
   Similar news · Read more »
   
4. First-ever 'State of the Carbon Cycle Report' finds troubling imbalance
   11-14-2007 · EurekAlert!
   The first "State of the Carbon Cycle Report" for North America, released online this week by the US Climate Change Science Program, finds the continent's carbon budget increasingly overwhelmed by human-caused emissions. North American sources release nearly 2 billion tons of carbon into the atmosphere each year, mostly as carbon dioxide. Carbon "sinks" such as growing forests may remove up to half this amount, but these current sinks may turn into new sources as climate changes.
   Similar news · Read more »
   
5. Chi-Chang Kao Named Chair of the National Synchrotron Light Source at Brookhaven Lab
   10-10-2006 · Brookhaven National Laboratory
   Chi-Chang Kao, a physicist and leader in synchrotron light research, has been named Chair of the National Synchrotron Light Source (NSLS) Department, effective October 1. Kao had served as interim NSLS Chair since mid-January, after Steve Dierker stepped down to lead the development of the National Synchrotron Light Source II (NSLS-II), a proposed scientific user facility that would produce x-rays more than 10,000 times brighter than the current NSLS.
   Similar news · Read more »
   
6. New HIV statistics indicate increasing toll of AIDS on African-American community
   11-16-2006 · EurekAlert!
   The country's leading African-American lawmakers, civil rights leaders and medical experts today called on the federal government to adopt and implement a new blueprint to address the HIV/AIDS crisis in the African-American community. The plan is outlined in a new report, African-Americans, Health Disparities and HIV/AIDS: Recommendations for Confronting the Epidemic in Black America, written by Robert E. Fullilove, EdD, associate dean at the Mailman School of Public Health.
   Similar news · Read more »
   
7. New HIV statistics indicate increasing toll of AIDS on African American community
   11-16-2006 · EurekAlert!
   The country's leading African American lawmakers, civil rights leaders and medical experts today called on the federal government to adopt and implement a new blueprint to address the HIV/AIDS crisis in the African American community. The plan is outlined in a new report, "African Americans, Health Disparities and HIV/AIDS: Recommendations for Confronting the Epidemic in Black America," written by Robert E. Fullilove, EdD, associate dean at the Mailman School of Public Health.
   Similar news · Read more »
   
8. What makes a good leader -- the assertiveness quotient
   02-04-2007 · EurekAlert!
   Organizational leaders who come across as low or high in assertiveness tend to be seen as less effective, according to a study coming out in the February issue of the Journal of Personality and Social Psychology, published by the American Psychological Association. Leaders in the middle may have an "optimal" level of assertiveness, but there is plenty of company on the extremes. The research suggests that being seen as under- or over-assertive may be the most common weakness among aspiring leaders.
   Similar news · Read more »
   
9. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
10. Oak Ridge to lead auto supplier R&D partnership
    01-17-2008 · Oak Ridge National Laboratory (ORNL)
    Oak Ridge National Laboratory will lead research and development work for the automotive supplier industry initiated through the U.S. Automotive Partnership for Advancing Research and Technologies, or USAutoPARTs collaborative announced today at the North American International Auto Show in Detroit.
    Similar news · Read more »